Interim HealthCare Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Interim HealthCare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11482
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interim HealthCare Inc (IHC), formerly Medical Personnel Pool Inc, is a healthcare service provider that offers home care and home health care services. The center provides senior care, pediatric nursing and physical, occupational and speech therapy. Its specialized homecare services include patient-centered dementia care, arthritis, congestive heart failure, huntington’s disease, blood pressure , coronary artery disease , diabetes , COPD, joint replacement, mental health and depression, home care support for multiple sclerosis, palliative care, paraplegia and quadriplegia, parkinson’s disease, pediatric care, traumatic brain injury, ventilator care, wound care and veterans care. It offers in-home care services such as health assessments, disease and treatment education, wound care, IV management, medication administration, foot care, and others. The center has its presence in the US and the UK. IHC is headquartered in Sunrise, Florida, the US.

Interim HealthCare Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interim HealthCare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deal Details 9
Private Equity 9
Halifax Group Completes Management Buyout Of Interim HealthCare 9
Acquisition 10
Interim HealthCare Acquires Just Better Care 10
Interim Healthcare Acquires Bluebird Care Franchises 11
Interim HealthCare Inc – Key Competitors 12
Interim HealthCare Inc – Key Employees 13
Interim HealthCare Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 16
Corporate Communications 16
Sep 06, 2018: Interim HealthCare announces new chief operating officer 16
Other Significant Developments 17
Aug 01, 2018: Interim HealthCare launches formal patient-centered ‘dementia program’ 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Key Facts 2
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interim HealthCare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Halifax Group Completes Management Buyout Of Interim HealthCare 9
Interim HealthCare Acquires Just Better Care 10
Interim Healthcare Acquires Bluebird Care Franchises 11
Interim HealthCare Inc, Key Competitors 12
Interim HealthCare Inc, Key Employees 13
Interim HealthCare Inc, Other Locations 14
Interim HealthCare Inc, Subsidiaries 15

List of Figures
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Interim HealthCare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Interim HealthCare Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis) a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • ASCO Group Ltd-石油・ガス分野:企業M&A・提携分析
    Summary ASCO Group Limited (ASCO) is a provider of supply chain management services to the global oil and gas sector and other related industries. The company offers a broad range of services covering logistics, fuels and lubricants, freight forwarding and environmental and waste management services …
  • Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer …
  • Nobelpharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company which develops medicines for rare diseases and unmet medical needs. The Company’s pipeline products include NPC-07, NPC-09, NPC-12, NPC-14, NPC-15, NPC-16, NPC-17 and NPC-18. It offers its products in the therapeutic areas of oncol …
  • Bank of the Ryukyus Ltd:企業の戦略・SWOT・財務分析
    Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Elcam Medical:企業の製品パイプライン分析2018
    Summary Elcam Medical (Elcam) is a medical device company that produces disposable medical devices and components for the OEM market, and provides novel solutions for specialized flow control needs. The company offers products, which are used in the areas of intensive care medicine, anesthesia, infe …
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …
  • Electricity Supply Board:企業の戦略・SWOT・財務分析
    Electricity Supply Board - Strategy, SWOT and Corporate Finance Report Summary Electricity Supply Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • GFT Technologies AG (GFT):企業の財務・戦略的SWOT分析
    Summary GFT Technologies AG (GFT Technologies) is a technology company that implements, develops, and maintains information technology solutions. The company’s services comprise application management, bespoke development, product based implementation, and business and IT consultation services. GFT …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • Holland America Line Inc:企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Smiths Group plc:戦略・SWOT・企業財務分析
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Biomm SA (BIOM3):企業の財務・戦略的SWOT分析
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Extendicare Inc.:企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cohera Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cohera Medical Inc (Cohera) is a medical device company that designs and develops surgical adhesives and sealants. The company provides products such as TissuGlu surgical adhesive, Sylys surgical sealant, and others. Its TissuGlu surgical adhesive is biocompatible for internal use, and forms …
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆